share_log

药明生物(02269.HK)获李革增持100万股普通股股份,价值约1,163.67万港元

Wuxi Bio (02269.HK) obtained shareholding of 1 million common shares by Li Ge, worth about HKD 11.6367 million.

Futu News ·  Jun 24 17:04

According to the documents disclosed by the Hong Kong Stock Exchange on June 24, Li Ge increased his shareholding on June 21 at an average price of HKD 11.6367 per share.$WUXI BIO (02269.HK)$Li Ge increased his shareholding by 1 million shares of ordinary shares, worth approximately HKD 11,636,700. After the increase, Li Ge's latest shareholding is 591 million shares, and the warehouse ratio has increased from 14.22% to 14.24%.

Supplementary information: Box 33: Mr. Zhaohui Zhang and Mr. Xiaozhong Liu continue to be concerted parties in respect of the 591,457,633 shares of the Company

HKEXAutoNews_DA20240623E00013.png

What is equity disclosure?

According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the company's shares) must disclose their shareholding in the listed company. Directors and senior executives of the listed company must disclose their shareholding and equity certificate rights in the listed company and any related companies.

Why is equity disclosure important?

Equity disclosure enables investors to identify (1) individuals who control or have the ability to control the shareholding of the listed company and (2) individuals who may benefit from transactions involving entities related to the listed company.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment